Algert Global LLC boosted its position in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 378.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 169,798 shares of the company's stock after purchasing an additional 134,338 shares during the period. Algert Global LLC owned about 0.41% of Varex Imaging worth $2,477,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the 4th quarter worth about $25,000. Quadrant Capital Group LLC lifted its position in Varex Imaging by 115.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock worth $41,000 after acquiring an additional 1,520 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Varex Imaging during the fourth quarter worth approximately $98,000. US Bancorp DE grew its position in shares of Varex Imaging by 149.8% in the fourth quarter. US Bancorp DE now owns 7,386 shares of the company's stock valued at $108,000 after purchasing an additional 4,429 shares during the last quarter. Finally, New York State Common Retirement Fund increased its stake in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after purchasing an additional 3,600 shares during the period.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on VREX shares. Oppenheimer reduced their target price on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. StockNews.com raised shares of Varex Imaging from a "hold" rating to a "buy" rating in a report on Friday, February 7th. Finally, B. Riley reaffirmed a "buy" rating and set a $22.00 target price (up from $21.00) on shares of Varex Imaging in a report on Friday, February 7th.
Check Out Our Latest Research Report on VREX
Insider Activity
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the company's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares in the company, valued at approximately $51,265.62. This represents a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sunny Sanyal sold 8,749 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $11.24, for a total value of $98,338.76. Following the sale, the chief executive officer now owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. This represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.
Varex Imaging Price Performance
Shares of VREX traded down $1.77 during midday trading on Friday, hitting $6.88. The company's stock had a trading volume of 951,429 shares, compared to its average volume of 572,589. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a one year low of $6.76 and a one year high of $16.93. The stock has a market capitalization of $283.46 million, a price-to-earnings ratio of -5.88 and a beta of 0.62. The company's fifty day simple moving average is $9.87 and its two-hundred day simple moving average is $12.71.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The business had revenue of $212.90 million during the quarter, compared to analysts' expectations of $206.76 million. During the same period in the prior year, the company earned $0.16 EPS. The firm's quarterly revenue was up 3.3% compared to the same quarter last year. As a group, equities analysts expect that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.
Varex Imaging Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
